false
0001582982
0001582982
2026-05-15
2026-05-15
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): May 15, 2026

CareCloud,
Inc.
(Exact
name of registrant as specified in its charter)
| Delaware |
|
001-36529 |
|
22-3832302 |
(State
or other jurisdiction
of incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
No.) |
7
Clyde Road, Somerset, New Jersey 08873
(Address of principal executive offices, zip code)
(732)
873-5133
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, par value $0.001 per share |
|
CCLD |
|
Nasdaq
Global Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
In
connection with the completion of the full redemption (the “Redemption”) discussed below and as further set forth on the
Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on April 14, 2026, CareCloud, Inc. (“the
Company”) notified the Nasdaq Global Market (the “Exchange”) on April 13, 2026 that all shares of its 8.75% Series
B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”) will be redeemed.
The Company requested that the Exchange (i) delist the Series B Preferred Stock from the Exchange and (ii) file with the Securities and
Exchange Commission a Form 25 Notification of Removal From Listing and/or Registration to delist and deregister the Series B Preferred
Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended. As a result, the Series B Preferred Stock was delisted
from the Exchange as of the close of business on May 14, 2026.
The
delisting of the Series B Preferred Stock does not affect the listing or trading of the Company’s common stock, which continues
to trade on the Exchange under the ticker symbol “CCLD.”
Item
8.01 Other Events.
The
information set forth in Item 3.01 above of this Current Report on Form 8-K is incorporated by reference herein.
On
May 15, 2026 (the “Redemption Date”), the Company completed the full Redemption of all issued and outstanding shares of its
Series B Preferred Stock, in accordance with the terms of the Certificate of Designation governing the Series B Preferred Stock, as previously
filed with the Delaware Secretary of State.
The
Redemption Price paid to each holder of record of the Series B Preferred Stock was $27.52 per share (the “Redemption Price”),
representing $25.25 per share plus all accumulated and unpaid dividends through but not including the Redemption Date. The aggregate
Redemption Price paid by the Company was approximately $41.6 million.
As
of the date of this Current Report on Form 8-K, all issued and outstanding shares of the Series B Preferred Stock have been redeemed,
all holders of the Series B Preferred Stock have been paid in full at the Redemption Price, and no shares of the Series B Preferred Stock
remain outstanding. Following the Redemption, the holders of the Series B Preferred Stock no longer have any rights with respect thereto,
other than the right to receive the Redemption Price in exchange for their shares.
Safe
Harbor Statement
Statements
contained in the exhibit that state the Company’s or its management’s expectations or predictions of the future are forward-looking
statements intended to be covered by the safe harbor provisions of the Securities Act of 1933, as amended, and the Securities Exchange
Act of 1934, as amended. It is important to note that the Company’s actual results could differ materially from those projected
in such forward-looking statements. The Company does not assume any obligations to update any of the forward-looking statements contained
in the exhibit to reflect events that occur or circumstances that exist after the date on which they were made.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE(S)
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
CareCloud, Inc. |
| |
|
|
| Date:
May 15, 2026 |
By: |
/s/
Norman Roth |
| |
|
Norman
Roth |
| |
|
Interim
Chief Financial Officer and Corporate Controller |